Stockreport

Clarus Therapeutics Announces $15 Million Private Placement

Clarus Therapeutics Holdings, Inc.  (CRXT) 
PDF Proceeds to support the ongoing commercialization of JATENZO® (testosterone undecanoate) NORTHBROOK, Ill., Dec. 03, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdi [Read more]